DE3867368D1 - 2-nitroimidazol-derivate, verwendbar als "radiosensitizers" fuer hypoxische tumorzellen. - Google Patents

2-nitroimidazol-derivate, verwendbar als "radiosensitizers" fuer hypoxische tumorzellen.

Info

Publication number
DE3867368D1
DE3867368D1 DE8888112377T DE3867368T DE3867368D1 DE 3867368 D1 DE3867368 D1 DE 3867368D1 DE 8888112377 T DE8888112377 T DE 8888112377T DE 3867368 T DE3867368 T DE 3867368T DE 3867368 D1 DE3867368 D1 DE 3867368D1
Authority
DE
Germany
Prior art keywords
radiosensitizers
tumor cells
hypoxic tumor
nitroimidazole derivatives
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888112377T
Other languages
German (de)
English (en)
Inventor
Mark James Suto
Leslie Morton Werbel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Application granted granted Critical
Publication of DE3867368D1 publication Critical patent/DE3867368D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/91—Nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DE8888112377T 1987-07-31 1988-07-29 2-nitroimidazol-derivate, verwendbar als "radiosensitizers" fuer hypoxische tumorzellen. Expired - Fee Related DE3867368D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/080,280 US4797397A (en) 1987-07-31 1987-07-31 2-nitroimidazole derivatives useful as radiosensitizers for hypoxic tumor cells

Publications (1)

Publication Number Publication Date
DE3867368D1 true DE3867368D1 (de) 1992-02-13

Family

ID=22156378

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888112377T Expired - Fee Related DE3867368D1 (de) 1987-07-31 1988-07-29 2-nitroimidazol-derivate, verwendbar als "radiosensitizers" fuer hypoxische tumorzellen.

Country Status (7)

Country Link
US (1) US4797397A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
EP (1) EP0302416B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS6463576A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AT (1) ATE71094T1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (1) DE3867368D1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ES (1) ES2038724T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GR (1) GR3003503T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8728418D0 (en) * 1987-12-04 1988-01-13 Jenkins T C Nitro-substituted aromatic/hetero-aromatic compounds for use in cancer treatment
US5036096A (en) * 1988-11-25 1991-07-30 Warner-Lambert Company Aziridino derivatives of nitroimidazoles and pharmaceutical compositions of selected derivatives
US5073639A (en) * 1988-11-25 1991-12-17 Warner-Lambert Company Process for the synthesis of novel and known nitroimidazoles which are useful as sensitizing agents
US5036089A (en) * 1988-11-25 1991-07-30 Warner-Lambert Company 2-oxazolidinone derivatives of nitroimidazoles and pharmaceutical compositions useful as sensitizing agents
US4954515A (en) * 1988-11-25 1990-09-04 Warner-Lambert Company Haloalkylaminomethyl-2-nitro-1H-imidazoles
GB9113487D0 (en) * 1991-06-21 1991-08-07 Amersham Int Plc Agents for hypoxic cells
US5432088A (en) * 1992-03-24 1995-07-11 The Toro Company Method and apparatus for aerobic composting
USD338756S (en) 1992-03-24 1993-08-24 The Toro Company Compost bin
US6855828B1 (en) 1992-11-19 2005-02-15 The Trustees Of The University Of Pennsylvania Detection of hypoxia
EP0669913B1 (en) * 1992-11-19 2003-03-05 The Trustees Of The University Of Pennsylvania Detection of hypoxia
US6252087B1 (en) 1992-11-19 2001-06-26 The Trustees Of The University Of Pennsylvania Nitroaromatic compounds for the detection of hypoxia
US5674693A (en) * 1994-03-18 1997-10-07 Natural Pharmacia International Inc. Derivatives of 2-nitro-imidazoles as hypoxic cell markers
US6060604A (en) * 1995-03-31 2000-05-09 Florida State University Pharmaceutical compounds comprising polyamines substituted with electron-affinic groups
US20050026974A1 (en) * 1996-02-08 2005-02-03 Trustees Of The University Of Pennsylvania Detection of hypoxia
RU2136628C1 (ru) * 1997-10-28 1999-09-10 Государственный научный центр Российской Федерации Всероссийский научно-исследовательский институт неорганических материалов им.акад.А.А.Бочвара СПОСОБ ПОЛУЧЕНИЯ ПОРОШКОВ СВЕРХПРОВОДЯЩЕЙ КЕРАМИКИ Bi - Pb - Sr - Ca - Cu - O
ATE457716T1 (de) 2002-12-30 2010-03-15 Angiotech Int Ag Wirkstofffreisetzung von schnell gelierender polymerzusammensetzung
US20040191843A1 (en) * 2003-02-03 2004-09-30 Palo Alto Institute Of Molecular Medicine Cell-killing molecules and methods of use thereof
US20040202694A1 (en) * 2003-04-11 2004-10-14 Vascular Control Systems, Inc. Embolic occlusion of uterine arteries
EP1838305A1 (en) 2005-01-21 2007-10-03 Richard H. Matthews Radiosensitizer formulations comprising nitrohistidine derivatives
US7875602B2 (en) * 2005-10-21 2011-01-25 Sutter West Bay Hospitals Camptothecin derivatives as chemoradiosensitizing agents
US9056136B2 (en) * 2006-10-06 2015-06-16 Natural Pharmacia International, Inc. Weakly basic 2-nitroimidazoles for the non-invasive detection of tissue hypoxia
US7842278B2 (en) * 2006-10-27 2010-11-30 Natural Pharmacia International, Inc. Hypoxia-selective, weakly basic 2-nitroimidazole delivery agents and methods of use thereof
WO2008090732A1 (ja) 2007-01-26 2008-07-31 Pola Pharma Inc. 医薬組成物
CN102933258A (zh) * 2010-03-01 2013-02-13 因特奥普医药公司 与含氧量低的细胞敏化剂联用的放疗
US9084806B2 (en) * 2012-11-12 2015-07-21 Research & Business Foundation Sungkyunkwan University Hypoxia-responsive nanoparticle for therapy and imaging of hypoxia-involving diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE45511B1 (en) * 1976-09-01 1982-09-08 Ciba Geigy Ag New derivatives of perhydro-aza-heterocycles and processesfor the production thereof
IE47132B1 (en) * 1977-08-19 1983-12-28 Roche Products Ltd Novel nitroimidazoles and pharmaceutical preparations containing these as well as their manufacture
US4282232A (en) * 1979-04-26 1981-08-04 Research Corporation Nitroimidazole radiosensitizers for hypoxic tumor cells and compositions thereof
EP0095906B1 (en) * 1982-05-27 1986-10-22 National Research Development Corporation Improvements relating to compounds useful in radiotherapy or chemotherapy

Also Published As

Publication number Publication date
GR3003503T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1993-03-16
EP0302416B1 (en) 1992-01-02
US4797397A (en) 1989-01-10
ATE71094T1 (de) 1992-01-15
JPS6463576A (en) 1989-03-09
ES2038724T3 (es) 1993-08-01
EP0302416A1 (en) 1989-02-08

Similar Documents

Publication Publication Date Title
DE3867368D1 (de) 2-nitroimidazol-derivate, verwendbar als "radiosensitizers" fuer hypoxische tumorzellen.
ZA881184B (en) Interstitial administration of perfluorochemical emulsions for reoxygenation of hypoxic tumor cells
NO174508C (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
SE8701933D0 (sv) Tetrahydronaphthalinderivate
DK233586A (da) 5-substituerede 1,3-thiazolidon-2,4-dion forbindelser og farmaceutiske praeparater indeholdende disse
NO172344C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte flavonoidforbindelser og salter
NO891232D0 (no) Arylhydrazoner.
DE68917485D1 (de) Pyridazinon-Derivate und diese enthaltende pharmazeutische Zubereitungen.
NO161564C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive beta-carbolin-3-oxadiazolylderivater.
FI852806L (fi) 2-substituerade -1,3-propylidendifosfonatderivat och deras framstaellning.
DK0474517T3 (da) Hidtil ukendt anvendelse af 1alfa-hydroxyleret-19-nor-vitamin D-
ATE91625T1 (de) Verwendung von porphyrinderivaten bei der entdeckung und behandlung von tumoren.
HU9303009D0 (en) New 2-saccharinyl-methyl-aryl-carboxylat derivatives and pharmaceutical preparations containing said compounds
FI853389L (fi) Tumoerlaekemedel och foerfarande foer dess framstaellning.
SE8602524L (sv) Kinolinderivat
AP8800109A0 (en) "Heterocyclic insecticides".
JPS5566547A (en) Alkene derivative*its manufacture and medicine containing it and having sexial excitement control activity
ATE10361T1 (de) Derivate von 3-phenoxy-2-propanolen, ihre herstellung und ihre therapeutische verwendung.
ATE46156T1 (de) 1,3-benzoxathiol-derivate, deren verwendung und deren herstellung.
FI882685A7 (fi) Pahanlaatuisten peräsuolikasvaimien hoitoon tarkoitettu laite ontelonsisäistä röntgenterapiaa varten
GR1000238B (el) Μεθοδος παρασκευης 3-(2-αλογονοαιθυλο)-1,4-οξαθειινων και 2-(2-αλογονοαιθυλο)-1,4-διθειινων.
SU1154907A1 (ru) Дигидрохлорид 3-(2-диэтиламиноэтилтио)-5-(2-морфолиноэтил)-1,2,4-триазино(5,6-в)индола, обладающий стресспротективной активностью
GB2185254A (en) Benzamide and nicotinamide radiosensitizers
DK223090D0 (da) Anvendelse af 1,2,4-benzotriazinoxider som straalingssensibiliserende midler og selektive cytotoksiske midler
GR3006108T3 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee